These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

655 related items for PubMed ID: 18978127

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Post-menopausal hormone replacement therapy (cont'd): risk-benefit balance in the hot seat.
    Prescrire Int; 2004 Jun; 13(71):106-9. PubMed ID: 15233153
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
    Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR, Women's Health Initiative Investigators.
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [Abstract] [Full Text] [Related]

  • 10. Hormone therapy. A year in review.
    Mayo Clin Womens Healthsource; 2003 Aug; 7(8):1-2. PubMed ID: 12925832
    [Abstract] [Full Text] [Related]

  • 11. [Hormone replacement therapy in menopause].
    Breckwoldt M.
    Dtsch Med Wochenschr; 2003 Feb 21; 128(8):400. PubMed ID: 12594630
    [No Abstract] [Full Text] [Related]

  • 12. Continuous low-dose combined hormone replacement therapy and the risk of endometrial cancer.
    Comerci JT, Fields AL, Runowicz CD, Goldberg GL.
    Gynecol Oncol; 1997 Mar 21; 64(3):425-30. PubMed ID: 9062144
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
    Romero M.
    Adv Nurse Pract; 2002 Nov 21; 10(11):47-8, 51-2. PubMed ID: 12478948
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Estrogen with and without progestin: benefits and risks of short-term use.
    LaCroix AZ.
    Am J Med; 2005 Dec 19; 118 Suppl 12B():79-87. PubMed ID: 16414331
    [Abstract] [Full Text] [Related]

  • 17. Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.
    Shapiro S.
    Climacteric; 2003 Dec 19; 6(4):302-10; discussion 310-3. PubMed ID: 15006251
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of tibolone and continuous combined conjugated equine oestrogens plus medroxyprogesterone acetate on progression of carotid intima-media thickness: the Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study.
    Bots ML, Evans GW, Riley W, McBride KH, Paskett ED, Helmond FA, Grobbee DE, OPAL Investigators.
    Eur Heart J; 2006 Mar 19; 27(6):746-55. PubMed ID: 16415304
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.